These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Lipocine has announced the commencement of a randomised Phase III clinical trial of LPCN 1154, an oral formulation of ...

The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

Purple Day, the international epilepsy awareness day, is today and it encourages people to wear purple and engage in ...

Cassava Sciences is ending simufilam development for Alzheimer's after Phase 3 trials failed. The company is shifting focus to potential seizure treatments.

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...

Cassava Sciences (NASDAQ:SAVA) lost ~19% in the premarket on Tuesday after the company announced plans to discontinue its ...

The first stage is a restructuring phase when a private company sets the groundwork for becoming publicly-traded. The IPO transaction phase usually occurs before the first public shares are sold.

Seizures happen when you have abnormal surges of electrical activity in the brain, potentially causing involuntary jerking, confusion, and sometimes loss of consciousness. It’s possible to have ...

During the search, police K-9s indicated the presence of narcotics and firearms, leading to a major seizure, the department said. Over the course of the operation, authorities said they seized 400 ...

Shares of Ola Electric Mobility dropped 5% to Rs 53.78 on Monday after a report revealed the company faced raids and seizures for alleged regulatory violations. Bloomberg highlighted that 95% of its ...

and treatment-refractory epilepsy. About Ventus Therapeutics Ventus Therapeutics is a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 development ...